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Abstract—An imaging system was developed for prostate elastography in vivo using a transrectal ultrasound
(US) probe to guide high-intensity focused US (HIFU) therapy of prostate cancer. Uniform compression was
applied using a balloon, while a sector image was acquired. Strain was calculated from the gradient of the
displacements obtained from the ultrasonic signal using the cross-correlation technique. Elastograms were
acquired on a total of 31 patients undergoing HIFU therapy for localised prostate cancer. For two patients, only
part of the prostate was treated and posttherapy magnetic resonance imaging (MRI) conﬁrmed the size and
position of the HIFU lesions seen in the elastograms as low strain areas, with a strain contrast ratio between 1.6
and 3.2. The whole prostate was treated for the next 29 patients. After treatment, the whole prostate appeared
to be stiff in the elastograms and a 40% to 60% (mean 50%) decrease in average strain was observed when
compared to strains measured before HIFU application. Tumours identiﬁed by biopsies and sonograms could
occasionally be seen in the preoperative elastograms. Decorrelation effects occurred mainly because of low
sonographic signal-to-noise ratio (SNR) and of out-of-plane motion induced by respiration. (E-mail:
souchon@lyon.inserm.fr) © 2003 World Federation for Ultrasound in Medicine & Biology.
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INTRODUCTION
Adenocarcinoma of the prostate is the most prevalent
malignant cancer and the second cause of cancer-speciﬁc
death in men in the USA. Therapy is more effective
when cancer is diagnosed at an early stage, but this
carcinoma is usually asymptomatic and, therefore, reli-
able diagnostic modalities are required. Accurate assess-
ment of the local extent of the disease is fundamentally
important in the selection of appropriate local treatment
modalities. There is currently a strong need for an im-
aging modality that could allow reliable detection of
prostate adenocarcinoma. Cancer is usually detected by
prostate-speciﬁc antigen (PSA) testing and screening, but
an elevated PSA is not speciﬁc to cancer. The “gold
standard” remains sextant biopsies guided by transrectal
US (TRUS) examination, but this process is a sampling
procedure that cannot exclude cancer with a 100% cer-
tainty. A thorough review of the strengths and weak-
nesses of existing imaging modalities for prostate cancer
can be found in El-Gabry et al. (2001). Digital rectal
examination (DRE) is commonly used for the diagnosis
of prostate cancer because it has been long known that
many tumours are stiffer than normal tissues. Available
data show a stiffness contrast ratio of 2 to 4 between
normal and cancerous tissues in the prostate in vitro
(Krouskop et al. 1998).
The physician has to determine what the appropriate
therapy for each patient should be. Watchful waiting
combined with hormonal therapy can avoid aggressive
treatments to low-risk patients. However, most patients
will expect, and may require, active treatment. High-
intensity focused ultrasound (HIFU) therapy of prostate
cancer (Chapelon et al. 1992; Foster et al. 1993; Mad-
ersbacher et al. 1995; Gelet et al. 2001) has been pro-
posed. This technique, also called focused ultrasound
surgery (FUS), creates short and local elevations of tem-
perature at the focus of an ultrasonic therapy transducer.
High ultrasonic intensity is maintained for a few s for the
target tissue to reach a thermal dose that creates irrevers-
ible local coagulation necrosis. Multiple elementary co-
Address correspondence to: Re ´mi Souchon, INSERM Unite ´ 556,
151 cours Albert Thomas, 69424 Lyon cedex 03, France. E-mail:
souchon@lyon.inserm.fr
Ultrasound in Med. & Biol., Vol. 29, No. 7, pp. 1007–1015, 2003
Copyright © 2003 World Federation for Ultrasound in Medicine & Biology
Printed in the USA. All rights reserved
0301-5629/03/$–see front matter
1007agulation lesions are generated to treat the whole pros-
tate. The therapy session is guided by transrectal diag-
nostic US. The major limitation of this technique lies in
the difﬁculty of assessing the extent of the induced
lesions. Earlier studies on porcine liver reported HIFU-
induced lesions as hypoechoic areas in sonograms (Bush
et al. 1993), but none deal with the prostate. From our
experience (Gelet et al. 2001), HIFU lesions in human
prostate remain invisible on the sonograms after the
dissipation of hyperechoic gas bubbles created during the
therapy. These bubbles are not representative of the
lesion. The lesions are devascularised and can be seen
using contrast-enhanced power Doppler, but this tech-
nique underestimates the extent of the HIFU lesion
(Sedelaar et al. 1999). MRI was proposed to monitor the
temperature changes in the body and/or to evaluate the
extent of the induced lesion (Hynynen et al. 1996; Rou-
vie `re et al. 2001), but the cost of MRI equipment may
restrict the availability of the method. Magnetic reso-
nance elastography (MRE) was also recently proposed to
assess the effects of thermal tissue ablation (Wu et al.
2001) by measuring mechanical properties of the lesion.
Ultrasonic techniques such as speed of sound (Lu et al.
1996), ultrasonic attenuation (Ribault et al. 1998) and
temperature measurements using US (Van Baren et al.
1996) have also been proposed to assess the extent of the
HIFU-induced lesions, with limited success. Shi et al.
(1999) detected HIFU lesions in porcine liver in vitro
using dynamic elastometry, a technique where Doppler
signals are used to measure the velocity of the tissues
while they are being vibrated at low frequency. Because
velocity depends on stiffness, this technique provides a
measurement of the elastic properties of the tissues.
Ultrasonic elastography (Ophir et al. 1991) is a new
imaging technique capable of showing local internal
strain in soft tissues undergoing a quasistatic compres-
sion. The resulting strain images, called elastograms,
provide information about the stiffness of the tissues.
Low strains can be seen in stiff areas, and high strains in
soft regions. The strain is estimated from the displace-
ments measured from the ultrasonic radiofrequency (RF)
signals generated by the US scanner before and after
slight tissue compression. Elastography has been used in
vivo to detect breast (Garra et al. 1997) and prostate
(Lorenz et al. 1999; Pesavento and Lorenz 2001) tu-
mours. It was also shown that local HIFU treatment
results in stiffened lesions in rabbit muscle, canine liver,
porcine liver and in bovine muscle, which makes them
detectable by elastography (Righetti et al. 1999; Shi et al.
1999; Wu et al. 2001).
This paper presents a new device for in vivo prostate
elastography via the transrectal route, designed to guide
HIFU treatment of prostate cancer by providing tumour
detection and visualisation of HIFU-induced lesions. An
elastographic system is combined with a commercially
available HIFU therapy device. Compression of the pros-
tate is applied by inﬂation of a transrectally placed bal-
loon. The acquisition system and the data-processing
scheme are described in the next section. Then, examples
of elastograms obtained in vivo using this device are
presented and compared to sonograms and MRI. Factors
inﬂuencing the quality of the elastograms in vivo are
discussed.
MATERIALS AND METHODS
Ultrasonic imaging
The imaging system is based on a commercially
available US scanner (Combison 311, Kretz, Austria),
equipped with a transrectal probe (IRW 77AK, Kretz,
Austria). The scanner was slightly modiﬁed to output the
analogue ultrasonic RF echo signal, the frame trigger and
the line trigger. The imaging probe is a rotating single-
element transducer with a ﬁxed focus. All acquisitions
were performed with the scanner operating at 5.5 MHz.
The scanner provides eight frames per s (fps) and a 0.4°
pitch. The transducer has a 52-mm focal length, a 35-mm
focal depth and a 40% bandwidth.
High-intensity focused ultrasound therapy device
The imaging system is connected to a HIFU ma-
chine designed for prostate cancer therapy (Ablatherm ,
Edap-Technomed, Lyon, France). The active part of the
system combines a HIFU therapy probe and an imaging
probe (Fig. 1), and is covered by a latex transducer cover
ﬁlled with a coupling liquid. It is mounted on a comput-
er-controlled motorised holder that allows a stable posi-
tioning of the probes. HIFU lesions were created using a
40-mm ﬁxed focus probe, 1.6-mm step between shots,
30-W acoustic power, 5-s duration and 5-s between
shots.
Compression and data acquisition
Compression of the prostate was applied by manu-
ally and continuously inﬂating the balloon using a 60-mL
syringe. Compressing using the balloon applies a uni-
form pressure and uniform stress on the rectal wall and,
thus, minimises artefacts due to nonuniform stress ﬁelds
(Konofagou et al. 1996). The amplitude of the stress
applied using the balloon is independent of the direction,
whereas the use of the imaging probe as a compressor
requires the use of a directional compensation for non-
uniform applied stress, and generates an angle-dependent
decrease in the elastographic signal-to-noise ratio
(SNRe) (Lorenz et al. 1999). Using the balloon, the
imaging probe can be attached to a motorised table to
avoid undesired manual motion. The counterpart is the
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pression using the probe.
RF data were acquired by a 12-bit analogue-to-
digital converter (ADC) operating at 60 MHz (Compu-
Scope CS6012/PCI, Gage, Ontario). The digitiser was
synchronised with the US scanner using the line and the
frame triggers. The ADC presents up to 67 ns jitter
between the trigger event and the time when the ﬁrst
sample was acquired. These jitters result in erroneous
displacement estimates. To avoid these errors, the RF
lines were realigned by adding a delayed version of the
line trigger to the RF signals, and using software detec-
tion of the delayed pulse. Subsample precision measure-
ment of the jitters was achieved by setting a constant
slope (1 mV/ns) to the delayed pulse. RF signals were
realigned numerically using the shifting property of the
Fourier transform. A  2 ns SD (residual jitter) was
found when detecting the synchronisation pulse on the
shifted signals.
Although elastography is meant to image quasistatic
strain assuming elastic materials, the time interval be-
tween the pre- and postcompression frames was kept
short to minimise decorrelation due to undesired motion
of the patient. Consecutive frames were acquired during
compression. The acquisition was triggered by the dis-
placement of the balloon on the central A-line in the
region-of-interest (ROI). This scheme ensures that a
known and uniform displacement is applied between
digitised frames. The position of the balloon was de-
tected and tracked by the software using simple thresh-
olding of the RF signal.
Elastographic data processing
RF data were ﬁltered by numerically removing fre-
quency components outside the transducer bandwidth to
minimise noise and interference. Strain was calculated
from the gradient of the displacements, which were es-
timated from the RF lines using the position of the
maximum of the cross-correlation function (Ophir et al.
1991), using two iterations. The ﬁrst iteration calculated
an elastogram using a 0.5% global stretching (Ce ´spedes
and Ophir 1993). This initial elastogram was smoothed
and used as an initial guess to perform local stretching
(Alam et al. 1998; Srinivasan et al. 2002) of the post-
compression RF. In a second iteration, the ﬁnal elasto-
gram was calculated using the locally stretched RF sig-
nals. Lateral motion estimation (Konofagou and Ophir
1998) was performed by searching for corresponding RF
segments on ﬁve adjacent A-lines (corresponding to 2°
aperture) to compensate for unavoidable lateral motion
in vivo. The normalised cross-correlation coefﬁcient and
the time delays were calculated using T  2 mm window
length (2.6 s) and T  0.4 mm window shift (80%
window overlap). A 5  5( 2m m 2°) median ﬁlter
was applied to the displacements before the gradient was
calculated. Using a 2-D median ﬁlter increases elasto-
graphic SNR at the cost of resolution, whereas the over-
all size of the image is unchanged. The length of the ﬁlter
kernel was matched to the window length to minimise
the additional loss in resolution.
At low frame rates, occasional decorrelation be-
tween frames prevented a systematic use of multicom-
pression; therefore, the elastograms were calculated us-
ing a single compression. In the future, occasional deco-
rrelations may be removed by detecting and eliminating
the respective frames from the calculation of the image.
Clinical trial
Elastograms were acquired from 31 patients who
underwent HIFU therapy for localised prostate cancer.
The patients were positioned on the table in lateral po-
sition, under general or spinal anaesthesia. The patients
were under the effects of anaesthetics for the purpose of
the therapy and, therefore, were not able to hold their
breath. A precompression was ﬁrst applied to ensure that
good contact was made between the balloon and the
rectal wall. On two patients, the precompression was
roughly estimated to be 15% to 20% of the initial an-
teroposterior (AP) dimension of the prostate, using the
thickness of the prostate measured on the posttherapy
MRI as a reference. The frame rate was initially 0.7 fps
Fig. 1. Experimental setup showing the imaging probe (white)
and the HIFU probe (black) inside the balloon, positioned in
front of the prostate (light grey) by transrectal route. The three
parallel imaging planes are shown (B  base, M  midgland,
A  apex).
HIFU lesions and elastography ● R. SOUCHON et al. 1009for patients A and B, and was subsequently increased up
to 8 fps for the following patients.
A 0.25-mm displacement step between frames was
chosen. The total tissue thickness between the balloon
and the pubic bone that conﬁnes the anterior part of the
prostate is usually in the range 35 to 45 mm, so the
0.25-mm displacement step corresponds to a 0.5 to 0.7%
average strain. This level of applied strain has been
shown to be in the optimal range for achieving maximum
elastographic contrast-to-noise ratio (Varghese and
Ophir 1997). Because limited time was available to ac-
quire elastograms during the therapy, only three elasto-
grams were acquired in parallel imaging planes at the
apex, midgland and base (Fig. 1). The limitation implies
that this study only reports incidental ﬁnding of the
tumour, as opposed to a systematic scan that should be
performed in a diagnostic application for effective tu-
mour detection. In a future application, the acquisition
could be performed over many planes to create a volu-
metric image.
The repeatability of the acquisition was veriﬁed by
an evaluation of the SD of the average strain inside the
prostate, measured from ten elastograms acquired at the
same location. Five independent measurements of the SD
were obtained from different patients.
Before the therapy session began, elastograms were
acquired to assess the feasibility of visualising prostate
tumours using our elastographic system. Biopsies and
sonograms were used as a reference to identify the tu-
mours. During the therapy session, elastograms were
acquired after one side of the prostate was treated, to
measure the strain contrast between the treated and un-
treated areas. Immediately after treatment, elastograms
were acquired to visualise the effects of the HIFU treat-
ment. On two patients, the size and position of the HIFU
lesion was estimated using MRI. Fat-saturated gadolini-
um-enhanced T1-weighted turbo spin echo (TSE) images
were acquired to visualise the HIFU lesions, as described
in Rouvie `re et al. (2001): all MR images were obtained
on a 1.5-T MR unit (Siemens Symphony, Erlangen,
Germany) using a pelvic phased-array coil, after IV
injection of 0.1 mmol/kg (0.2 mL/kg) of gadoterate me-
glumine (Guerbet Dotarem, Roissy, France). The follow-
ing parameters were used: TR 1.093 ms, effective TE 12
ms, slice thickness 4 mm, interslice gap 0.4 mm, 3
excitations, echo train of 3, 30% phase oversampling and
frequency-selective fat saturation. This technique was
shown to provide accurate visualisation of HIFU-in-
duced lesions, but not to predict the existence of residual
viable cancer. MRI scans were acquired 48 h after ther-
apy, whereas elastograms were acquired no later than 5
min after the end of the treatment. The distance from the
imaging plane to the apex served as a reference for
registration with the elastograms. The strain contrast
ratio between healthy tissues and the ROI (tumour or
HIFU lesion) was estimated. The average strain was
measured for the whole prostate, for the ROI (tumour or
HIFU lesion), and for the prostatic tissues outside the
area of interest. The prostate and tumour contours were
manually delineated from the sonogram. The HIFU le-
sion contours, not visible on the sonogram, were chosen
from the elastogram. Areas of excessive decorrelation
(correlation p  0.75) were excluded when measuring
the average strain. For the patients who did not have MRI
performed, changes in the tissues were evaluated from
the variation of the average strain inside the prostate
before and after treatment.
RESULTS
Prostate tumours
Because of the limited number of elastograms ac-
quired and of the lack of histopathologic conﬁrmation,
only a few carcinomas could be observed and reliably
conﬁrmed. In at least three cases, prostate tumours con-
ﬁrmed by biopsies and sonograms were seen in the
elastograms, appearing as stiff areas. Histopathologic
conﬁrmation was not available because the prostate is
not removed after HIFU therapy. Two cases are pre-
sented that conﬁrm the feasibility of using elastography
to detect some prostate cancers.
Figure 2 shows the sonogram and the corresponding
elastogram acquired for patient A, diagnosed with T2
(TNM classiﬁcation) carcinoma. The prostate (black out-
line) and the tumour (white outline) were manually de-
lineated from the sonogram. The tumour is visible on the
sonogram as a hypoechoic area, and on the elastogram as
a stiff area in the right posterior part (bottom) of the
image. Biopsies conﬁrmed the presence of a carcinoma
in this region. The black area at the bottom of the
sonogram is the liquid inside the balloon. The prostate is
seen as a hypoechoic area that contains two hyperechoic
Fig. 2. Patient A: (a) Sonogram and (b) elastogram of the
prostate (black outline) and the tumour (white outline). The
images are 60  45 mm in size. In the elastogram, the grey-
scale corresponds to 0 (black) to 1.5% (white) strain and areas
where correlation is less than 0.75 are hidden by a medium grey
mask.
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ows. The two calciﬁcations are clearly depicted as low
strain areas surrounded by strain concentrations, as ex-
pected from experiments with phantoms containing a
stiff inclusion (Souchon et al. 2002). The sonographic
shadows behind the two calciﬁcations generate an area of
corresponding decorrelation noise in the elastogram. Be-
tween the two calciﬁcations, the urethra is visible as a
central area of high strains. A third stiff nodule, neither
visible on the sonogram nor found by biopsies, can be
seen on the elastogram between the calciﬁcations. On the
elastogram, a white rim of high strains outlines the edge
of the prostate capsule (which is a thin soft layer around
the prostate,  1-mm thick). It corresponds to a soft layer
of fatty periprostatic tissues. The average strain is 0.19%
inside the tumour and 0.72% outside (strain contrast ratio
of 3.8). A stiff area can also be seen on the left and might
possibly show a tumour not visible in B-mode. Decor-
relation areas are observed inside the balloon, due to the
low sonographic SNRs in the liquid, and around the
prostate. Decorrelation on the right side of the elasto-
gram is associated with low SNRs, whereas possible slip
conditions may be responsible for the decorrelation
along the left side of the image.
Figure 3 presents the corresponding sonograms and
elastograms for patient B, who was diagnosed with T2
carcinoma. The tumour (white outline) has similar loca-
tion and shape in both images. Biopsies conﬁrmed the
location of the carcinoma. The strain contrast ratio be-
tween the tumour (0.08% strain) and the other tissues
(0.76% strain) is 9.5. The elastogram also shows two
unidentiﬁed stiff areas, and noisy strain estimates that are
mostly associated with low SNRs in sonographic shad-
ows.
HIFU lesions during the therapy session
In Fig. 4, the corresponding sonogram and elasto-
gram are shown for patient B during HIFU therapy. The
target area (arrows) was 18 mm high starting from the
rectal wall, and 25 mm wide (the left side of the gland).
On the sonogram, a large part of the prostate has a
hyperechoic appearance because of the presence of cav-
itation gas bubbles created during the application of
HIFU. These bubbles disappear after a few min and are
not representative of the position and size of the HIFU
lesion. On the elastogram, the HIFU lesion (white out-
line) is shown as a stiff (dark) area that extends laterally
on 35 mm from the left edge of the image to the central
part, and penetrates up to 20 mm from the rectal wall
toward the anterior face of the prostate. The HIFU lesion
exceeds the target width but, outside the target area, its
penetration depth is only 10 mm. The right end side and
the anterior side (top of the image) are not treated and are
depicted as soft tissues (bright). The large size and the a
priori knowledge of the location of the HIFU lesion
make it easier to detect than tumours. Measurements
inside the prostate show a 0.32% average strain in the
HIFU lesion and 1.01% outside the lesion (strain contrast
ratio of 3.2).
HIFU lesions immediately after the therapy session
Figure 5 shows the corresponding MRI and elasto-
gram for patient A after HIFU treatment. The HIFU
lesion is expected to spread laterally over the whole
Fig. 3. Patient B: (a) Sonogram and (b) elastogram of the
tumour (white outline) (60  45 mm images, grey-scale 0 to
1.5% strain).
Fig. 4. Patient A: (a) MRI and (b) elastogram of the HIFU
lesion (white outline). The shape and size of the lesion are
similar in both images. Two calciﬁcations can be seen inside
the HIFU lesion (arrows) (60  45 mm image, grey-scale 0 to
1.5% strain).
Fig. 5. Patient B: (a) Sonogram and (b) elastogram of a single-
sided HIFU lesion (white outline) during the therapy. The
lesion is not visible from the sonogram (60  45 mm images,
grey-scale 0 to 1.5% strain).
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into the prostate starting from the boundary between the
rectum and the prostate. The rectal wall and deep pros-
tatic tissues should be undamaged. The HIFU lesion
(white outline) is depicted on the elastogram by a stiff
area that extends 18 to 22 mm deep starting from the
rectal wall. Deeper tissues show higher strains, and im-
portant decorrelation noise due to low SNRs in this area.
The average strain is 0.36% inside the HIFU lesion and
0.56% in untreated tissues (strain contrast ratio of 1.6).
The two calciﬁcations that were observed before HIFU
therapy (Fig. 2) can be seen inside the HIFU lesion (two
arrows). The MR image shows the HIFU lesion as a
hypointense zone (white outline) surrounded by a hyper-
intense peripheral rim of oedema that appeared over 48 h
following HIFU therapy. MRI resolution and SNR are
similar to those reported by Rouvie `re et al. (2001). Sharp
contours are not seen in the MRI, probably because of
the inﬂammatory aspect of the oedema. The MR image
conﬁrms the slightly asymmetrical shape of the HIFU
lesion. Both MRI and elastogram show that the rectum
and the anterior part (top of image) of the prostate were
not damaged. The surface of the HIFU lesion represents
57% of the surface of the prostate on the elastogram, and
44% on the MRI. The discrepancy may arise from the
changes in volume that occurred in the prostate during
the 48 h elapsed between elastogram and MRI acquisi-
tion (Rouvie `re et al. 2001). The direction of the imaging
planes in elastograms and in MRI may also be slightly
different.
Figure 6 presents the corresponding MRI and elas-
togram for patient B after HIFU treatment. The HIFU
lesion is expected be have similar characteristics as for
patient A. The lesion (white outline) is depicted on the
elastogram by a low strain area that extends 15 to 18 mm
deep starting from the rectal wall, leaving an untreated
area in deeper tissues. The average strain is 0.42% inside
the HIFU lesion and 0.77% in untreated tissues (strain
contrast ratio of 1.8). The urethra is visible as a central
spot of high strains. The urethra is visible as a circular
central black area on the MR image because of the
presence of a transurethral catheter (the catheter was not
present when elastograms were acquired). The MR im-
age conﬁrms that the HIFU lesion extends over the full
width of the prostate, and is bounded by the rectal wall
and the plane of the urethra. The surface of the HIFU
lesion represents 51% of the surface of the prostate on
the elastogram, and 47% on the MRI. The rectum and the
anterior part of the prostate appear undamaged in both
the MRI and the elastogram.
Variation of the average strain after HIFU therapy
When measuring the average strain inside the pros-
tate over a series of 10 elastograms acquired at the same
location, the SD varied between 4% and 15%. The re-
peatability of the elastograms was deemed satisfactory to
measure reliable strain contrasts. The increased frame
rate used for the 29 patients included in the statistics
eliminated the occurrence of useless, noisy elastograms
that were often seen at low frame rate on the ﬁrst two
patients.
A large variation of the average strain was mea-
sured between patients, ranging from 0.4 to 1.5% before
therapy, and from 0.1 to 0.9% after therapy. Therefore,
the absolute value of the strain was not considered to be
a relevant parameter when comparing the results of dif-
ferent patients. The average strain after therapy was
found to be 40% to 60% (mean 50%) of the average
strain before therapy. This result is equivalent to a 1.7 to
2.5 (mean 2.0) contrast ratio between normal and ne-
crosed tissues and is consistent with the strain contrast
ratio measured between the HIFU lesion and undamaged
tissues after therapy (1.6 to 3.2) for patients A and B.
DISCUSSION
In three cases, stiff areas corresponding to biopsy-
proven tumours visible on sonograms were observed in
the elastograms acquired before HIFU therapy. How-
ever, the research protocol did not allow for a full scan of
the prostate (only three scans were acquired) and tumour
detection was, therefore, only incidental. Histologic con-
ﬁrmation of the tumours was not possible because the
prostate is not removed after HIFU therapy. The results
are, nevertheless, promising because they conﬁrm the
feasibility of detecting prostate tumours using elastogra-
phy. More tumours could be detected in a clinical im-
plementation where the whole prostate can be scanned
(Pesavento and Lorenz 2001). Krouskop et al. (1998)
reported a 1.6 stiffness contrast ratio between healthy
prostatic tissues and malignant tumours at 2% precom-
pression, and a 3.5 stiffness contrast at 4% precompres-
sion in vitro. However, during our investigations, the
level of precompression was much higher, approximately
Fig. 6. Patient B: (a) MRI and b) elastogram showing the HIFU
lesion (white outline) after HIFU therapy. (60  45 mm image,
0 to 1.5% strain).
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lated. High strain contrast ratios (3.8 to 9.5) were mea-
sured between the tumours and other prostatic tissues.
The urethra was often seen as a central spot of high
strains, as expected from prior work in vitro (Kallel et al.
1999).
The HIFU lesions were clearly seen on the elasto-
grams as stiff areas, and were conﬁrmed by MRI. This
demonstrates the feasibility of using elastography to as-
sess the extent of the treated region immediately after
HIFU therapy was performed. It was also possible to
brieﬂy interrupt the therapy to acquire elastograms that
showed the HIFU lesion; thus, showing that elasto-
graphic guidance would be possible to detect and target
untreated areas. Real-time monitoring using elastography
while the tissues are being heated could be possible and
would allow accurate targeting, but may be challenging
because both stiffness and speed of sound depend on
temperature. The strain contrast ratio measured in vivo
between normal tissues and HIFU lesions in the prostate
in vivo was 1.6 to 3.2, which is larger than, and consistent
with, the strain contrast threshold (1.3 to 1.5) used by
Righetti et al. (1999) to differentiate HIFU lesions from
normal tissues in canine liver in vitro. A difference may
exist because of the different nature of liver and prostate
tissues and of the use of different boundary conditions,
so comparison with in vitro results should be made
carefully. The strain contrast ratio is also likely to vary
during prostate cooling after HIFU application, because
of the temperature-dependence of the stiffness of tissues
(Wu et al. 2001). No signiﬁcant contrast was observed on
the elastograms between the cancerous areas and the
healthy tissues after the HIFU lesions were created (i.e.,
the tumours were no longer visible inside the HIFU
lesion). The eventual presence of residual cancer could
not be detected in the elastograms. The average strain in
the prostate was shown to decrease by 40% to 60% after
treatment in 29 patients. A small decrease after treatment
may indicate incomplete treatment and a risk of local
recurrence. In the future, the relative value of the average
strain after treatment may be used as an indicator of
treatment efﬁciency.
Strain contrast may be improved by optimising the
amount of precompression (i.e., using the nonlinear
properties of tissues), because prostate tumours were
reported to behave nonlinearly (Krouskop et al. 1998).
Setting strain contrast thresholds in vivo is also made
difﬁcult by the unclear dependence of strain on depth,
which was theoretically expected using a cylindrical
compression model (Souchon et al. 2002), but not ob-
served in vivo. Ponnekanti et al. (1992 showed a reduc-
tion in strain decay inside a material compressed be-
tween two parallel plates. Similarly, the external conﬁne-
ment of the anterior part of the prostate by the pubic bone
is likely to reduce the effect of strain decay.
Sonographic SNR
A major cause of decorrelation in the elastograms
presented in this article is the low sonographic SNR in
parts of the prostate, due either to hypoechoic tissues,
ultrasonic attenuation, or shadow areas. Figure 7 shows
the average normalised cross-correlation coefﬁcient plot-
ted as a function of SNR for every time delay estimation
performed during the calculation of the elastogram pre-
sented in Fig. 2. The average correlation decreased from
0.98 at 50 dB SNR down to 0.9 at 15 dB SNR, and a
steeper decrease was observed for SNRs below 15 dB
(Ce ´spedes et al. 1997). The SD increased with decreas-
ing SNR. These results explain a large part of the deco-
rrelation noise present in the elastograms in vivo.I tc a n
be seen that the correlation coefﬁcient and, therefore, the
quality of the elastogram, is strongly dependent on the
sonographic SNR (Fig. 7). The use of a high-transmit
gain on the US scanner could improve the quality of the
elastograms. The presence of hyperechoic gas bubbles
induced by HIFU therapy enhances the SNR and is,
therefore, beneﬁcial to the quality of the elastograms.
Undesired motion
The transducer was attached to a motorised table to
avoid any undesired motion of the imaging probe. How-
ever, any sporadic motion of the patient will degrade the
quality of the elastograms. Motion of the prostate was
observed in addition to the displacement due to the
compression. When the patient is positioned in a lateral
position on the table and no compression is applied,
real-time longitudinal sonography shows that the pros-
Fig. 7. Normalised cross-correlation coefﬁcient vs. SNRs cor-
responding to the elastogram presented in Fig. 2b.
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This displacement is variable among patients and can be
as high as 5 mm. This is much larger than the eventual
out-of-plane displacement that could be generated when
inﬂating the balloon by steps of 0.25 mm. 3-D motion
was dominated by respiratory motion, with the major
component perpendicular to the imaging planes, and
similar on each plane. In transverse elastograms, this
out-of-plane motion is critical. At 0.7 fps (patients A and
B), many acquisitions failed due to poor correlation
between frames. Using a higher frame rate (8 fps), ac-
quisition failures no longer occurred because the out-of-
plane displacement between frames was minimised. The
frame rate could be dramatically improved using more
advanced software and/or hardware, as shown by Pesav-
ento and Lorenz (2001) who reported signiﬁcant results
in vivo in prostate cancer detection using real-time strain
imaging. In the future, using high frame rates will allow
cumulative displacements to be added to induce larger
strains.
The displacements of the prostate due to respiration
was seen as lateral motion on the longitudinal B-scans.
This observation suggests that respiratory motion could
be measured and, therefore, compensated for by acquir-
ing elastograms in longitudinal scans and estimating
lateral displacements (Konofagou and Ophir 1998). Al-
ternatively, this motion itself might be used for the
generation of elastograms, instead of externally applied
compression.
CONCLUSION
A new imaging system was developed for in vivo
elastography of the human prostate, using a balloon
compression by transrectal route. Elastograms were ac-
quired in three planes (apex, median, base) on a total of
31 patients undergoing HIFU therapy of localised pros-
tate cancer. The SD of the average strain in the prostate,
measured from the elastograms, ranged from 4 to 15%
(of the average strain), thus demonstrating that the ac-
quisitions could be reliably repeated. Increasing the
frame rate up to 8 fps was necessary to achieve better
interframe correlation and obtain easily repeatable elas-
tograms.
Using this elastographic system, we were able to
visualise HIFU lesions inside the prostate in vivo during
and immediately after the therapy. The HIFU lesions
were clearly visible as low strain areas, even in the
presence of confounding gas bubbles as seen on the
sonograms. The hyperechoic appearance of the bubbles
increased the sonographic SNR in the prostate and was,
therefore, beneﬁcial for the quality of the elastograms.
The size and position of the HIFU lesions seen on the
elastograms matched the expected lesion, and were con-
ﬁrmed by MRI in two patients. A strain contrast between
1.6 and 3.2 was measured between the stiff HIFU lesion
and healthy tissues. It was also possible to brieﬂy inter-
rupt the therapy process to acquire elastograms that
showed the extent of the lesion and to resume the ther-
apy; thus, demonstrating the feasibility of using elastog-
raphy to guide HIFU therapy. After the whole prostate is
treated, the average strain inside the prostate was shown
to decrease by 40% to 60% in 29 patients when com-
pared to the average strain measured at the same location
before treatment. Variations in this parameter may be
related to the intensity of the lesion. Prostate tumours
conﬁrmed by biopsies and sonograms were occasionally
seen in the elastograms, appearing as stiff areas, but a
systematic scan of the whole prostate would be necessary
in a clinical application for effective tumour detection.
Decorrelation occurred because of low sonographic
SNR in hypoechoic areas and of out-of-plane motion,
which was mainly induced by respiration. In a future
application, these undesired effects could be minimised
by breath-holding, higher frame rates (Pesavento and
Lorenz 2001) and a high transmit gain.
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